Back to Search
Start Over
Adrenomedullin(27–52) inhibits vascular calcification in rats
- Source :
- Regulatory Peptides. 129:125-132
- Publication Year :
- 2005
- Publisher :
- Elsevier BV, 2005.
-
Abstract
- Adrenomedullin (ADM) has the vasodilatory properties and involves in the pathogenesis of vascular calcification. ADM could be degraded into more than six fragments in the body, including ADM(27-52), and we suppose the degrading fragments from ADM do the same bioactivities as derived peptides from pro-adrenomedullin. The present study carries forward by assessing the effects on vascular calcification of the systemic administration of ADM(27-52). The rat vascular calcific model was replicated with vitamin D3 and nicotine. ADM or/and ADM(27-52) were systemically administrated with mini-osmotic pump beginning at seventh day after the model replication for 25 days. Vascular calcific nodules histomorphometry, vascular calcium content, vascular calcium uptake, alkaline phosphatase activity, and osteopontin-mRNA quantification in aorta were assessed. ADM limited 40.2% vascular calcific nodules (P0.01), did not effect on calcium content (P0.05), reduced 44.4% calcium uptake (P0.01), lowered 21.1% alkaline phosphatase activity (P0.01), and regulated 40.9% downwards osteopontin-mRNA expression (P0.01) in the aorta of rats with vascular calcification. ADM(27-52) receded 32.0% vascular calcific nodules (P0.01), taken from 55.5% calcium content (P0.01), did not affect calcium uptake (P0.05), inhibited 22.5% alkaline phosphatase activity (P0.01), and restrained 21.9% osteopontin-mRNA expression (P0.01) in the aorta of rats with vascular calcification. Both of ADM and ADM(27-52) did interact on vascular calcification each other. ADM could partially antagonize the effects of ADM(27-52) in taking from calcium content (17.5%, P0.01) and in receding vascular calcific nodules (18.6%, P0.01). ADM could obviously enhance the action of ADM(27-52) in inhibiting alkaline phosphatase activity (14.4%, P0.01) and in reducing calcium uptake (11.4%, P0.01). ADM(27-52) could partially antagonize the effects of ADM on regulating downwards osteopontin-mRNA expression (17.0%, P0.01). It is concluded that ADM(27-52) derived from ADM acts as an inhibitory agent on vascular calcification, with special mechanisms different from ADM derived from ADM progenitor molecule.
- Subjects :
- Male
Nicotine
medicine.medical_specialty
Physiology
Clinical Biochemistry
Aorta, Thoracic
Vasodilation
Biology
Biochemistry
Rats, Sprague-Dawley
Pathogenesis
Adrenomedullin
Cellular and Molecular Neuroscience
chemistry.chemical_compound
Endocrinology
Calcinosis
medicine.artery
Internal medicine
medicine
Animals
Nicotinic Agonists
Cholecalciferol
Aorta
medicine.disease
Peptide Fragments
Rats
chemistry
Alkaline phosphatase
Calcification
Subjects
Details
- ISSN :
- 01670115
- Volume :
- 129
- Database :
- OpenAIRE
- Journal :
- Regulatory Peptides
- Accession number :
- edsair.doi.dedup.....675d152aca0cc71bdec25bfec805876a
- Full Text :
- https://doi.org/10.1016/j.regpep.2005.02.017